Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 70+
Code: NCT04750551
Recruiting
Clareon TruPlus Study
for
Aphakia, Astigmatism
Location: Sugar Land TX, Mt. Pleasant SC, Phoenix AZ,
Sponsor: Alcon Research
Sex: All
Age: 22+
Code: NCT07502456
Recruiting
tACS for Sensory Motor Recovery After Stroke
for
Motor Recovery
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 70+
Code: NCT06029062
Recruiting
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
for
Smoking, Tobacco
Location: Houston TX, Dallas TX, St Louis MO, Atlanta GA,
Sponsor: RAI Services Company
Sex: All
Age: 21 - 65
Code: NCT07598136
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: Houston TX, Fort Worth TX, Indianapolis IN, Aurora CO,
Sponsor: Allterum Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07586618
Phase1, Recruiting
BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment After a Long-term Use (Pilot).
for
Motor Recovery
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 70+
Code: NCT04752319
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Houston TX, Pasadena TX, Humble TX, Missouri City TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase3, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Houston TX, Temple TX, San Antonio TX, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for
Interstitial Lung Diseases,
Location: Houston TX, San Antonio TX, Birmingham AL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06806592
Phase3, Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
for
CLL/SLL
Location: Houston TX, Kingswood TX, Peoria IL, Jacksonville FL,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT06104566
Phase3, Recruiting
A Study of ZW251 in Participants With Advanced Solid Tumors
for
Hepatocellular Carcinoma,
Location: Houston TX, San Antonio TX, Louisville KY,
Sponsor: Zymeworks BC Inc.
Sex: All
Age: 18+
Code: NCT07164313
Phase1, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Bellaire TX, Cedar Park TX, Arlington TX, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)